Tech Company Financing Transactions
Metabolic Solutions Development Funding Round
Metabolic Solutions Development closed a $10 million venture capital round on 5/12/2009. Backers included Hopen Life Science Ventures and Southwestern Michigan First Life Science Venture Fund.
Transaction Overview
Company Name
Announced On
5/12/2009
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Proceeds Purpose
The funding from investors supports the compilation and analysis of Phase IIa data and allows MSDC to pursue an Investigational New Drug Application with the Food and Drug Administration on a second-generation drug to MSDC-0160.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
161 East Michigan Ave. 4th Floor
Kalamazoo, MI 49007
USA
Kalamazoo, MI 49007
USA
Phone
Website
Email Address
Overview
Metabolic Solutions Development Company was formed in January 2006 to develop innovative therapeutics addressing the growing global threat of type 2 diabetes and other metabolic disorders. Its founders are two scientists with decades of experience in type 2 diabetes and other metabolic disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stephen Benoit
Chief Scientific Officer
Jerry Colca
Co-Founder
Rolf Kletzien
Browse more venture capital transactions:
Prev: 5/12/2009: Medialets venture capital transaction
Next: 5/13/2009: Dashwire venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs